Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease

被引:26
作者
Ayoub, Fares [1 ]
Trillo-Alvarez, Cesar [2 ]
Morelli, Giuseppe [3 ]
Lascano, Jorge [4 ]
机构
[1] Univ Florida, Dept Med, 1600 SW Archer Rd, Gainesville, FL 32608 USA
[2] Univ Florida, Dept Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32608 USA
[3] Univ Florida, Dept Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL 32608 USA
[4] Univ Florida, Dept Med, Adult Cyst Fibrosis Ctr, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32608 USA
关键词
Cystic fibrosis liver disease; Hepatic steatosis; Non-alcoholic fatty liver disease;
D O I
10.4254/wjh.v10.i1.34
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM To investigate the clinical, biochemical and imaging characteristics of adult cystic fibrosis (CF) patients with hepatic steatosis as compared to normal CF controls. METHODS We performed a retrospective review of adult CF patients in an academic outpatient setting during 2016. Baseline characteristics, genetic mutation analysis as well as laboratory values were collected. Abdominal imaging (ultrasound, computed tomography, magnetic resonance) was used to determine presence of hepatic steatosis. We compare patients with hepatic steatosis to normal controls. RESULTS Data was collected on 114 patients meeting inclusion criteria. Seventeen patients (14.9%) were found to have hepatic steatosis on imaging. Being overweight (BMI > 25) (P = 0.019) and having a higher ppFEV1 (75 vs 53, P = 0.037) were significantly associated with hepatic steatosis. Patients with hepatic steatosis had a significantly higher median alanine aminotransferase level (27 vs 19, P = 0.048). None of the hepatic steatosis patients had frank CF liver disease, cirrhosis or portal hypertension. We found no significant association with pancreatic insufficiency or CF related diabetes. CONCLUSION Hepatic steatosis appears to be a clinically and phenotypically distinct entity from CF liver disease. The lack of association with malnourishment and the significant association with higher BMI and higher ppFEV1 demonstrate similarities with non-alcoholic fatty liver disease. Long term prospective studies are needed to ascertain whether CF hepatic steatosis progresses to fibrosis and cirrhosis.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 42 条
  • [1] Hepatobiliary Abnormalities and Disease in Cystic Fibrosis Epidemiology and Outcomes Through Adulthood
    Bhardwaj, Sidharth
    Canlas, Karen
    Kahi, Charles
    Temkit, M'Hamed
    Molleston, Jean
    Ober, Michael
    Howenstine, Michelle
    Kwo, Paul Y.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (09) : 858 - 864
  • [2] US Cannot Be Used to Predict the Presence or Severity of Hepatic Steatosis in Severely Obese Adolescents
    Bohte, Anneloes E.
    Koot, Bart G. P.
    van der Baan-Slootweg, Olga H.
    Rijcken, Tammo H. Pels
    van Werven, Jochem R.
    Bipat, Shandra
    Nederveen, Aart J.
    Jansen, Peter L. M.
    Benninga, Marc A.
    Stoker, Jaap
    [J]. RADIOLOGY, 2012, 262 (01) : 327 - 334
  • [3] PATHOPHYSIOLOGY OF GASTROINTESTINAL COMPLICATIONS OF CYSTIC-FIBROSIS
    BOROWITZ, D
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 15 (05) : 391 - 401
  • [4] Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients
    Cantón, R
    Cobos, N
    de Gracia, J
    Baquero, F
    Honorato, J
    Gartner, S
    Alvarez, A
    Salcedo, A
    Oliver, A
    García-Quetglas, E
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (09) : 690 - 703
  • [5] CF Foundation, 2015, PAT REG ANN DAT REP
  • [6] DEFECTIVE INTRACELLULAR-TRANSPORT AND PROCESSING OF CFTR IS THE MOLECULAR-BASIS OF MOST CYSTIC-FIBROSIS
    CHENG, SH
    GREGORY, RJ
    MARSHALL, J
    PAUL, S
    SOUZA, DW
    WHITE, GA
    ORIORDAN, CR
    SMITH, AE
    [J]. CELL, 1990, 63 (04) : 827 - 834
  • [7] ANALYSIS OF RISK-FACTORS FOR THE DEVELOPMENT OF LIVER-DISEASE ASSOCIATED WITH CYSTIC-FIBROSIS
    COLOMBO, C
    APOSTOLO, MG
    FERRARI, M
    SEIA, M
    GENONI, S
    GIUNTA, A
    SERENI, LP
    [J]. JOURNAL OF PEDIATRICS, 1994, 124 (03) : 393 - 399
  • [8] Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome
    Colombo, C
    Battezzati, PM
    Crosignani, A
    Morabito, A
    Costantini, D
    Padoan, R
    Giunta, A
    [J]. HEPATOLOGY, 2002, 36 (06) : 1374 - 1382
  • [9] Liver disease in cystic fibrosis
    Colombo, Carla
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2007, 13 (06) : 529 - 536
  • [10] Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease
    Debray, Dominique
    Kelly, Deirdre
    Houwen, Roderick
    Strandvik, Birgitta
    Colombo, Carla
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2011, 10 : S29 - S36